U.S. Mobile Physician Practice Market Size & Share to Surpass USD 323.68 Bn, at a 6.7% CAGR By 2033

The U.S. mobile physician practice market size was exhibited at USD 169.23 billion in 2023 and is projected to Surpass USD 323.68 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2024 to 2033.

Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8388

U.S. Mobile Physician Practice Market Key Takeaways:

• The emergency medicine segment dominated the market with the largest revenue share of 44.1% in 2023.
• The telehealth segment is expected to grow at the fastest CAGR of 7.4% during the forecast period from 2024 to 2033.
• The primary care segment dominated the market with the largest revenue share of 19.3% in 2023.
• The rehabilitation services material segment is estimated to register the fastest CAGR of 7.8% over the forecast period from 2024 to 2033.
• The home healthcare segment dominated the market with the largest revenue share of 42.1% in 2023.
• The hospices segment is expected to grow at the fastest CAGR of 8.3% over the forecast period from 2024 to 2033.

The market growth is attributed to factors such as the increasing incidence of chronic disorders, the increasing number of people who require home aid, and the rising cost of visits to healthcare facilities. Chronic diseases are among the most prevalent and costly health conditions in the U.S. and have become a major cause of disabilities, requiring medical attention. According to the Partnership to Fight Chronic Disease (PFCD), 164 million people in U.S., around 49% of the total population, are expected to be affected by chronic diseases by 2025.

Moreover, the introduction of technologically advanced medical devices that allow physicians to remotely monitor their patients is expected to drive the market for mobile physician practices over the forecast period. By using advanced management software, medical practitioners can easily book appointments and keep track of patient medical records. The geriatric population suffers from general age-related disabilities, such as dementia, diabetes, heart conditions, Alzheimer’s disease, and mental stress. Such medical conditions are anticipated to subsequently drive the demand for house calls by physicians who provide quality medical care to this cohort at a reduced cost. Also, supportive initiatives undertaken by regulatory authorities, such as the development of the Centers for Medicare & Medicaid Services (CMS) is expected to impel market growth. CMS facilities provide advanced mobile medical services at a reduced cost.

Mobile physician practice services are covered under Medicare Part B. Most medical practitioners accept Medicare as a payment method, wherein approximately 80% is covered by Medicare and 20% is covered by secondary insurance via copay, according to annual deductibles. Secondary or third-party insurance coverage from insurance bodies, such as Cigna, Aetna, and Blue Cross Blue Shield, is also accepted by mobile physician practice services.

These practices provide on-site medical care to patients in their homes, meeting the increasing demand for personalized healthcare services. Mobile physician practices offer convenience and accessibility, especially for individuals with limited mobility or residing in remote areas. Additionally, advancements in telemedicine enable physicians to remotely monitor patients and provide consultations, leading to improved healthcare outcomes thereby aiding the growth of the U.S. mobile physician practice market.

Mobile practices offer a cost-effective solution by eliminating overhead expenses associated with physical clinics, resulting in more affordable healthcare services for patients. Furthermore, these practices can help reduce healthcare expenses by providing proactive and timely care, reducing the need for costly hospital or emergency room visits. The rising cost of healthcare facility visits has driven the demand for affordable and accessible alternatives such as mobile physician practices, boosting the market growth.

U.S. Mobile Physician Practice Market By Type Insights

The emergency medicine segment dominated the market with the largest revenue share of 44.1% in 2023. The dominance is attributed to the increasing presence of the geriatric population, which requires frequent medical interventions. The increasing cost of visits to emergency medical departments, longer wait times, and understaffed emergency rooms (ER) have made it difficult for patients to get quality care.

U.S. Mobile Physician Practice Market By Services Insights

The primary care segment dominated the market with the largest revenue share of 19.3% in 2023. Primary care mobile practice provides routine check-ups, preventive care, and general consultation. Additionally, by providing primary care directly to patients, these practices enhance accessibility for patients with limited mobility.

The rehabilitation services material segment is estimated to register the fastest CAGR of 7.8% over the forecast period from 2024 to 2033. The growth of the segment can be attributed to the increasing use of these practices in the treatment of patients recovering from surgeries, injuries, or strokes. Mobile rehabilitation practices provide targeted interventions, exercises, and therapies in the comfort of patients' homes, promoting faster recovery, improved functional outcomes, and reduced hospital readmissions.

U.S. Mobile Physician Practice Market By End-use Insights

The home healthcare segment dominated the market with the largest revenue share of 42.1% in 2023. The dominance is attributed to the convenience and comfort offered by mobile physician practice services. Long-term care centers collaborate with mobile physician services instead of maintaining in-house physicians, nursing practitioners, or assistants. Such collaborations allow these facilities to reduce the high cost of maintaining in-house medical practitioners. Most of the people receiving homecare in the U.S., are aged above 65 years, with approximately 97% of them requiring assistance while taking the bath and 91% of them requiring aid while transferring in and out of bed.

Mobile physician practice providers offer group care packages that allow patients to schedule home calls with medical practitioners for routine checkups or medical emergencies. Mobile physicians use telehealth software for remote patient monitoring for residents of these facilities. The payment of such services is generally covered by Medicare or third-party insurance. Uninsured patients can make out-of-pocket payments to service providers.

Some of the prominent players in the U.S. mobile physician practice market include:

• Mobile Physician Services, Inc.
• TeamHealth
• Doctor On Demand by Included Health, Inc.
• Florida Mobile Physicians, LLC
• PriveMD
• PatientPop, Inc.
• SOS Doctor Housecall

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. mobile physician practice market

Type

• Emergency Medicine
• Telehealth
• Others

Services

• Primary Care
• Short-Term Episodic Care
• Monitoring Services
• Wound Care
• Pain Management
• Rehabilitation Services
• Palliative Care
• Others

End-use

• Home Healthcare
• Hospices
• Nursing Care
• Assisted Living Facility

Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8388 ?

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected] | +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India

Call: USA - + 1 804 441 9344| IND - + 91 87933 22019 | Europe: +44 2080772818

[email protected]

Web: https://www.novaoneadvisor.com/

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to com

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size ?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size ?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market? size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size ?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size ?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size ?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size ?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size ?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size ?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.